MorphoSys AG (MOR)
19.00
-0.34
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
18.98
-0.02
(-0.11%)
After-Hours: 20:00
MorphoSys Unrealized Gain or Loss - Total (Quarterly)
Unrealized Gain or Loss - Total (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Unrealized Gain or Loss - Total (Quarterly) Data
Date | Value |
---|---|
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
June 30, 2017 | -- |
March 31, 2017 | -- |
December 31, 2016 | -- |
September 30, 2016 | -- |
June 30, 2016 | -- |
March 31, 2016 | -- |
December 31, 2015 | -- |
September 30, 2015 | -- |
June 30, 2015 | -- |
Date | Value |
---|---|
March 31, 2015 | -- |
December 31, 2014 | -- |
September 30, 2014 | -- |
June 30, 2014 | -- |
March 31, 2014 | -- |
December 31, 2013 | -- |
September 30, 2013 | -- |
June 30, 2013 | -- |
March 31, 2013 | -- |
December 31, 2012 | -- |
September 30, 2012 | -- |
June 30, 2012 | -- |
March 31, 2012 | -- |
December 31, 2011 | -- |
Unrealized Gain or Loss Definition
Unrealized Gain or Loss is the change in value of the assets or liabilities held by a company that haven't yet been realized through a transaction. These gains or losses are present on a company's balance sheet but have not resulted from an actual sale. A positive Unrealized Gain or Loss value indicates that the company holds assets that have appreciated in value but have not yet be realized. A negative Unrealized Gain or Loss indicates that the company holds an asset or investment whose valu...
Unrealized Gain or Loss - Total (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Unrealized Gain or Loss - Total (Quarterly) Benchmarks
Novartis AG | -- |
Immatics NV | -- |
Affimed NV | -- |
InflaRx NV | -- |
BioNTech SE | -- |